Axa Total Revenue vs Ebit Per Revenue Analysis

EQH Stock

USD 47.62 0.82 1.75%

Axa Equitable financial indicator trend analysis is way more than just evaluating Axa Equitable Holdings prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Axa Equitable Holdings is a good investment. Please check the relationship between Axa Equitable Total Revenue and its Ebit Per Revenue accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Axa Equitable Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

Total Revenue vs Ebit Per Revenue

Total Revenue vs Ebit Per Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Axa Equitable Holdings Total Revenue account and Ebit Per Revenue. At this time, the significance of the direction appears to have weak relationship.

The correlation between Axa Equitable's Total Revenue and Ebit Per Revenue is 0.37. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Ebit Per Revenue in the same time period over historical financial statements of Axa Equitable Holdings, assuming nothing else is changed. The correlation between historical values of Axa Equitable's Total Revenue and Ebit Per Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of Axa Equitable Holdings are associated (or correlated) with its Ebit Per Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit Per Revenue has no effect on the direction of Total Revenue i.e., Axa Equitable's Total Revenue and Ebit Per Revenue go up and down completely randomly.

Correlation Coefficient

0.37

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Total Revenue

Total revenue comprises all receipts Axa Equitable Holdings generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Ebit Per Revenue

Most indicators from Axa Equitable's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Axa Equitable Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Axa Equitable Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

As of now, Axa Equitable's Selling General Administrative is increasing as compared to previous years. The Axa Equitable's current Enterprise Value Over EBITDA is estimated to increase to 7.52, while Tax Provision is forecasted to increase to (718.2 M).

	2021	2022	2023	2024 (projected)
Gross Profit	6.6B	10.4B	6.3B	7.5B
Total Revenue	11.0B	12.6B	10.5B	9.3B

Gross Profit Total Revenue

Axa Equitable fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab
Common Stock Shares Outstanding		-0.88	0.55	-0.45	0.8	0.66	-0.91	0.66	0.6	0.44	-0.83	-0.03	-0.75	-0.66	-0.5	0.29	0.51	-0.73	-0.36	0.08	0.58	-0.66	-0.87	-0.75	0.99	-0.92
Total Assets	-0.88		-0.38	0.59	-0.69	-0.25	0.99	-0.26	-0.52	-0.26	0.95	-0.13	0.63	0.42	0.66	-0.08	-0.35	0.68	-0.07	0.18	-0.32	0.49	0.84	0.77	-0.87	0.99
Short Long Term Debt Total	0.55	-0.38		-0.33	0.47	0.43	-0.44	0.42	0.53	0.54	-0.48	-0.41	-0.37	-0.35	0.01	0.85	0.03	-0.47	-0.46	0.06	0.92	-0.34	-0.34	-0.42	0.58	-0.42
Other Current Liab	-0.45	0.59	-0.33		-0.23	-0.01	0.62	-0.06	0.04	-0.35	0.48	-0.27	0.07	-0.09	0.68	-0.16	-0.45	0.86	-0.25	0.45	-0.31	-0.04	0.38	0.57	-0.49	0.59
Total Current Liabilities	0.8	-0.69	0.47	-0.23		0.53	-0.7	0.55	0.81	0.18	-0.6	-0.14	-0.88	-0.78	-0.53	0.26	0.61	-0.44	-0.35	0.38	0.47	-0.83	-0.77	-0.64	0.8	-0.71
Total Stockholder Equity	0.66	-0.25	0.43	-0.01	0.53		-0.32	1.0	0.47	0.55	-0.23	-0.26	-0.65	-0.81	-0.05	0.35	0.51	-0.47	-0.89	0.58	0.57	-0.69	-0.4	-0.25	0.66	-0.34
Other Liab	-0.91	0.99	-0.44	0.62	-0.7	-0.32		-0.33	-0.52	-0.27	0.94	-0.06	0.64	0.45	0.65	-0.1	-0.39	0.75	-0.01	0.14	-0.39	0.51	0.87	0.79	-0.89	0.99
Net Tangible Assets	0.66	-0.26	0.42	-0.06	0.55	1.0	-0.33		0.47	0.58	-0.23	-0.28	-0.65	-0.81	-0.13	0.35	0.54	-0.51	-0.88	0.59	0.58	-0.7	-0.39	-0.23	0.67	-0.35
Net Debt	0.6	-0.52	0.53	0.04	0.81	0.47	-0.52	0.47		0.35	-0.61	-0.58	-0.9	-0.82	-0.35	0.38	0.11	-0.23	-0.5	0.59	0.51	-0.89	-0.43	-0.2	0.64	-0.52
Retained Earnings	0.44	-0.26	0.54	-0.35	0.18	0.55	-0.27	0.58	0.35		-0.36	-0.45	-0.32	-0.36	-0.21	0.66	0.0	-0.52	-0.6	0.16	0.69	-0.33	0.03	0.07	0.54	-0.29
Accounts Payable	-0.83	0.95	-0.48	0.48	-0.6	-0.23	0.94	-0.23	-0.61	-0.36		0.11	0.64	0.43	0.53	-0.17	-0.08	0.61	0.01	0.11	-0.39	0.51	0.72	0.61	-0.82	0.94
Cash	-0.03	-0.13	-0.41	-0.27	-0.14	-0.26	-0.06	-0.28	-0.58	-0.45	0.11		0.36	0.43	-0.05	-0.4	0.34	-0.02	0.5	-0.6	-0.46	0.45	-0.19	-0.45	-0.07	-0.1
Non Current Assets Total	-0.75	0.63	-0.37	0.07	-0.88	-0.65	0.64	-0.65	-0.9	-0.32	0.64	0.36		0.95	0.46	-0.13	-0.41	0.42	0.52	-0.64	-0.36	0.98	0.61	0.39	-0.76	0.65
Non Currrent Assets Other	-0.66	0.42	-0.35	-0.09	-0.78	-0.81	0.45	-0.81	-0.82	-0.36	0.43	0.43	0.95		0.27	-0.16	-0.43	0.34	0.73	-0.79	-0.39	0.98	0.48	0.24	-0.67	0.46
Other Assets	-0.5	0.66	0.01	0.68	-0.53	-0.05	0.65	-0.13	-0.35	-0.21	0.53	-0.05	0.46	0.27		0.12	-0.55	0.64	-0.19	0.04	-0.1	0.38	0.47	0.37	-0.55	0.64
Long Term Debt	0.29	-0.08	0.85	-0.16	0.26	0.35	-0.1	0.35	0.38	0.66	-0.17	-0.4	-0.13	-0.16	0.12		-0.1	-0.2	-0.53	0.01	0.91	-0.13	0.01	-0.08	0.38	-0.12
Cash And Short Term Investments	0.51	-0.35	0.03	-0.45	0.61	0.51	-0.39	0.54	0.11	0.0	-0.08	0.34	-0.41	-0.43	-0.55	-0.1		-0.57	-0.19	0.18	0.14	-0.39	-0.58	-0.59	0.5	-0.39
Net Receivables	-0.73	0.68	-0.47	0.86	-0.44	-0.47	0.75	-0.51	-0.23	-0.52	0.61	-0.02	0.42	0.34	0.64	-0.2	-0.57		0.17	0.07	-0.49	0.35	0.56	0.6	-0.74	0.72
Good Will	-0.36	-0.07	-0.46	-0.25	-0.35	-0.89	-0.01	-0.88	-0.5	-0.6	0.01	0.5	0.52	0.73	-0.19	-0.53	-0.19	0.17		-0.71	-0.6	0.61	0.02	-0.12	-0.4	0.01
Short Term Investments	0.08	0.18	0.06	0.45	0.38	0.58	0.14	0.59	0.59	0.16	0.11	-0.6	-0.64	-0.79	0.04	0.01	0.18	0.07	-0.71		0.1	-0.76	0.06	0.29	0.1	0.14
Long Term Debt Total	0.58	-0.32	0.92	-0.31	0.47	0.57	-0.39	0.58	0.51	0.69	-0.39	-0.46	-0.36	-0.39	-0.1	0.91	0.14	-0.49	-0.6	0.1		-0.35	-0.31	-0.29	0.64	-0.38
Non Current Liabilities Total	-0.66	0.49	-0.34	-0.04	-0.83	-0.69	0.51	-0.7	-0.89	-0.33	0.51	0.45	0.98	0.98	0.38	-0.13	-0.39	0.35	0.61	-0.76	-0.35		0.5	0.25	-0.67	0.52
Capital Surpluse	-0.87	0.84	-0.34	0.38	-0.77	-0.4	0.87	-0.39	-0.43	0.03	0.72	-0.19	0.61	0.48	0.47	0.01	-0.58	0.56	0.02	0.06	-0.31	0.5		0.88	-0.8	0.87
Other Current Assets	-0.75	0.77	-0.42	0.57	-0.64	-0.25	0.79	-0.23	-0.2	0.07	0.61	-0.45	0.39	0.24	0.37	-0.08	-0.59	0.6	-0.12	0.29	-0.29	0.25	0.88		-0.69	0.79
Other Stockholder Equity	0.99	-0.87	0.58	-0.49	0.8	0.66	-0.89	0.67	0.64	0.54	-0.82	-0.07	-0.76	-0.67	-0.55	0.38	0.5	-0.74	-0.4	0.1	0.64	-0.67	-0.8	-0.69		-0.91
Total Liab	-0.92	0.99	-0.42	0.59	-0.71	-0.34	0.99	-0.35	-0.52	-0.29	0.94	-0.1	0.65	0.46	0.64	-0.12	-0.39	0.72	0.01	0.14	-0.38	0.52	0.87	0.79	-0.91

Click cells to compare fundamentals

Axa Equitable Account Relationship Matchups

Axa Equitable fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	493.6M	450.4M	417.4M	379.9M	351.6M	391.5M
Total Assets	249.9B	282.3B	292.3B	252.7B	276.8B	272.9B
Short Long Term Debt Total	10.5B	4.1B	5.1B	5.2B	4.7B	5.6B
Other Current Liab	(2.1B)	(2.8B)	13.9B	(714M)	(2.7B)	(2.5B)
Total Current Liabilities	2.1B	2.8B	2.8B	3.0B	254M	241.3M
Total Stockholder Equity	13.5B	15.6B	11.5B	1.4B	2.6B	2.5B
Other Liab	215.6B	251.1B	272.3B	232.4B	267.3B	237.9B
Net Tangible Assets	7.7B	11.0B	5.2B	(3.4B)	(3.0B)	(2.9B)
Net Debt	(294M)	(2.1B)	(66M)	950M	(4.5B)	(4.2B)
Retained Earnings	11.8B	10.7B	8.9B	9.8B	10.2B	8.8B
Accounts Payable	2.1B	2.8B	2.7B	2.2B	2.7B	2.5B
Cash	4.4B	6.2B	5.2B	4.3B	8.2B	6.1B
Non Current Assets Total	79.5B	93.8B	88.2B	74.2B	248.6B	261.0B
Non Currrent Assets Other	(79.5B)	(93.8B)	(88.2B)	(1.2B)	229.7B	241.2B
Other Assets	159.4B	93.5B	181.6B	81.1B	147.3B	130.0B
Long Term Debt	6.4B	4.1B	5.0B	4.5B	5.4B	4.6B
Cash And Short Term Investments	4.4B	88.2B	5.2B	4.3B	9.4B	8.9B
Net Receivables	6.6B	6.8B	17.3B	11.6B	12.2B	10.2B
Good Will	4.6B	4.6B	4.6B	5.1B	5.1B	5.3B
Short Term Investments	66.3B	82.0B	79.9B	64.9B	1.5B	1.4B
Long Term Debt Total	6.4B	4.1B	3.9B	3.3B	3.0B	4.4B
Liabilities And Stockholders Equity	249.9B	282.3B	292.3B	252.7B	276.8B	272.9B
Non Current Liabilities Total	4.7B	4.9B	5.0B	3.3B	271.4B	285.0B
Capital Surpluse	1.9B	2.0B	1.9B	2.3B	2.6B	1.8B
Other Current Assets	14.2B	21.3B	27.6B	29.7B	18.8B	18.2B
Other Stockholder Equity	88M	(260M)	(931M)	(998M)	(1.4B)	(1.3B)
Total Liab	234.4B	265.0B	278.7B	249.1B	271.7B	258.6B
Deferred Long Term Liab	5.9B	749M	5.5B	8.2B	7.4B	4.5B
Long Term Investments	74.7B	109.1B	105.1B	93.1B	75.2B	84.7B
Short Long Term Debt	2.9B	546M	92M	759M	254M	241.3M
Total Current Assets	11.0B	95.0B	22.5B	97.4B	28.2B	42.6B
Accumulated Other Comprehensive Income	840M	3.9B	2.0B	(9.0B)	(7.8B)	(7.4B)
Short Term Debt	4.1B	4.1B	92M	759M	254M	241.3M
Intangible Assets	4.8B	4.7B	4.7B	5.5B	5.4B	4.5B
Cash And Equivalents	4.4B	6.2B	5.2B	4.3B	3.9B	4.0B
Net Invested Capital	16.9B	18.7B	15.1B	5.3B	6.7B	11.6B
Warrants	365M	143M	468M	455M	523.3M	356.0M
Noncontrolling Interest In Consolidated Entity	1.6B	1.6B	1.6B	1.7B	2.0B	1.8B
Retained Earnings Total Equity	11.8B	10.7B	8.9B	9.9B	8.9B	8.9B

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether Axa Equitable Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axa Equitable's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axa Equitable Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axa Equitable Holdings Stock:

How To Invest In Axa

Details

Is Axa Stock a good investment?

Details

What is Axa Equitable's Net Worth?

Details

Largest Diversified Financial Services Companies

View

Largest Insurance - Diversified Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Axa Equitable Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Is Diversified Financial Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axa Equitable. If investors know Axa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axa Equitable listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.40)

Dividend Share

0.22

Earnings Share

(0.91)

Revenue Per Share

32.942

Quarterly Revenue Growth

(0.25)

The market value of Axa Equitable Holdings is measured differently than its book value, which is the value of Axa that is recorded on the company's balance sheet. Investors also form their own opinion of Axa Equitable's value that differs from its market value or its book value, called intrinsic value, which is Axa Equitable's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axa Equitable's market value can be influenced by many factors that don't directly affect Axa Equitable's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Axa Equitable's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axa Equitable is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axa Equitable's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Axa Total Revenue vs Ebit Per Revenue Analysis

Total Revenue vs Ebit Per Revenue

Total Revenue vs Ebit Per Revenue Correlation Analysis

Correlation Coefficient

Total Revenue

Ebit Per Revenue

Axa Equitable fundamental ratios Correlations

Axa Equitable Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Axa Equitable fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Tangible Assets	+ 1.0	Total Stockholder Equity
Other Stockholder Equity	+ 0.99	Common Stock Shares Outstanding
Other Liab	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Assets
Total Liab	+ 0.99	Other Liab
Non Current Liabilities Total	+ 0.98	Non Current Assets Total

Total Liab	- 0.92	Common Stock Shares Outstanding
Total Liab	- 0.91	Other Stockholder Equity
Other Liab	- 0.91	Common Stock Shares Outstanding
Non Current Assets Total	- 0.9	Net Debt
Non Current Liabilities Total	- 0.89	Net Debt
Other Stockholder Equity	- 0.89	Other Liab